Hospital-Acquired Disease Testing Market Size, Trends, Analysis, and Outlook By Test (Urinary Tract Infection, Surgical Site Infection, Pneumonia Stents, Blood Stream Infection, Methicillin-Resistant Staphylococcus Aureus, Others), By End-User (Hospitals

Hospital-Acquired Disease Testing Market Size, Trends, Analysis, and Outlook By Test (Urinary Tract Infection, Surgical Site Infection, Pneumonia Stents, Blood Stream Infection, Methicillin-Resistant Staphylococcus Aureus, Others), By End-User (Hospitals and Intensive Care Units (ICUS), Ambulatory Surgical and Diagnostic Centers, Nursing Homes, Maternity Centers), by Region, Country, Segment, and Companies, 2024-2030

The global Hospital-Acquired Disease Testing market size is poised to register 7.25% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hospital-Acquired Disease Testing market across By Test (Urinary Tract Infection, Surgical Site Infection, Pneumonia Stents, Blood Stream Infection, Methicillin-Resistant Staphylococcus Aureus, Others), By End-User (Hospitals and Intensive Care Units (ICUS), Ambulatory Surgical and Diagnostic Centers, Nursing Homes, Maternity Centers).

The hospital-acquired disease testing market is witnessing notable growth, propelled by increasing focus on infection prevention and control, rising incidence of healthcare-associated infections (HAIs), and growing demand for rapid diagnostic solutions in hospital settings. Hospital-acquired diseases, also known as nosocomial infections, are infections acquired by patients during their stay in healthcare facilities, which can lead to increased morbidity, mortality, and healthcare costs if not promptly identified and treated. Healthcare providers are utilizing a range of diagnostic tests including molecular assays, immunoassays, and microbiological cultures to detect and identify pathogens responsible for HAIs such as Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and multidrug-resistant gram-negative bacteria, to implement timely infection control measures and prevent transmission within healthcare settings. With a focus on surveillance, antimicrobial stewardship, and quality improvement initiatives, infection control practitioners, clinical microbiologists, and hospital epidemiologists are collaborating to implement comprehensive strategies for HAI prevention and management, including targeted screening, environmental monitoring, and antimicrobial resistance surveillance. Additionally, advancements in rapid diagnostic technologies, point-of-care testing devices, and digital surveillance systems, along with integration with electronic health record (EHR) systems and infection control software platforms, are driving market expansion as stakeholders seek innovative and integrated solutions for detecting, monitoring, and controlling hospital-acquired infections and enhancing patient safety and quality of care in healthcare facilities.

Hospital-Acquired Disease Testing Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hospital-Acquired Disease Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hospital-Acquired Disease Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hospital-Acquired Disease Testing industry.

Key market trends defining the global Hospital-Acquired Disease Testing demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Hospital-Acquired Disease Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Hospital-Acquired Disease Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hospital-Acquired Disease Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Hospital-Acquired Disease Testing industry

Leading Hospital-Acquired Disease Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hospital-Acquired Disease Testing companies.

Hospital-Acquired Disease Testing Market Study- Strategic Analysis Review

The Hospital-Acquired Disease Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Hospital-Acquired Disease Testing Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Hospital-Acquired Disease Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Hospital-Acquired Disease Testing Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Hospital-Acquired Disease Testing Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Hospital-Acquired Disease Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Hospital-Acquired Disease Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Hospital-Acquired Disease Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Hospital-Acquired Disease Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Hospital-Acquired Disease Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Hospital-Acquired Disease Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Hospital-Acquired Disease Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hospital-Acquired Disease Testing in Asia Pacific. In particular, China, India, and South East Asian Hospital-Acquired Disease Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Hospital-Acquired Disease Testing Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Hospital-Acquired Disease Testing Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hospital-Acquired Disease Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hospital-Acquired Disease Testing.

Hospital-Acquired Disease Testing Market Company Profiles

The global Hospital-Acquired Disease Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are 3M, Abbott, Becton, Dickinson and Company, BIOMÉRIEUX, Cantel Medical, Cepheid Inc, Diatherix Laboratories, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Getinge AB, Hologic Inc, Life Technologies, Luminex Corp, Medtronic, Meridian Bioscience Inc, Olympus Corp, QIAGEN, Siemens Healthcare Private Ltd, Thermo Fisher Scientific Inc

Recent Hospital-Acquired Disease Testing Market Developments

The global Hospital-Acquired Disease Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Hospital-Acquired Disease Testing Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Test

Urinary Tract Infection

Surgical Site Infection

Pneumonia Stents

Blood Stream Infection

Methicillin-Resistant Staphylococcus Aureus

Others

By End-User

Hospitals and Intensive Care Units (ICUS)

Ambulatory Surgical and Diagnostic Centers

Nursing Homes

Maternity Centers

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

3M

Abbott

Becton, Dickinson and Company

BIOMÉRIEUX

Cantel Medical

Cepheid Inc

Diatherix Laboratories

Eurofins Scientific

F. Hoffmann-La Roche Ltd

Getinge AB

Hologic Inc

Life Technologies

Luminex Corp

Medtronic

Meridian Bioscience Inc

Olympus Corp

QIAGEN

Siemens Healthcare Private Ltd

Thermo Fisher Scientific Inc

Formats Available: Excel, PDF, and PPT